These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 31510053
81. Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine. Stangou M, Papagianni A, Bantis C, Moisiadis D, Kasimatis S, Spartalis M, Pantzaki A, Efstratiadis G, Memmos D. Clin Nephrol; 2013 Sep; 80(3):203-10. PubMed ID: 23611517 [Abstract] [Full Text] [Related]
82. Complement components, proteolysis‑related, and cell communication‑related proteins detected in urine proteomics are associated with IgA nephropathy. Mucha K, Bakun M, Jaźwiec R, Dadlez M, Florczak M, Bajor M, Gala K, Pączek L. Pol Arch Med Wewn; 2014 Sep; 124(7-8):380-6. PubMed ID: 24938435 [Abstract] [Full Text] [Related]
83. Cyclic neutropenia and concomitant IgA nephropathy: a case report. Kapogiannis C, Zaggogianni T, Stergiou N, Kakleas K, Kapogiannis A, Gakiopoulou H, Kanaka-Gantenbein C. BMC Nephrol; 2023 May 03; 24(1):124. PubMed ID: 37138249 [Abstract] [Full Text] [Related]
84. Candidate Urine Peptide Biomarkers for IgA Nephropathy: Where Are We Now? Marek-Bukowiec K, Konieczny A, Ratajczyk K, Witkiewicz W. Dis Markers; 2018 May 03; 2018():5205831. PubMed ID: 29606986 [Abstract] [Full Text] [Related]
85. The product of duration and amount of proteinuria (proteinuria index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy. Eiro M, Katoh T, Kuriki M, Asano K, Watanabe K, Watanabe T. Nephron; 2002 Apr 03; 90(4):432-41. PubMed ID: 11961402 [Abstract] [Full Text] [Related]
86. Proteomic approach for identification of IgA nephropathy-related biomarkers in urine. Prikryl P, Vojtova L, Maixnerova D, Vokurka M, Neprasova M, Zima T, Tesar V. Physiol Res; 2017 Sep 22; 66(4):621-632. PubMed ID: 28406696 [Abstract] [Full Text] [Related]
87. Markers for the progression of IgA nephropathy. Maixnerova D, Reily C, Bian Q, Neprasova M, Novak J, Tesar V. J Nephrol; 2016 Aug 22; 29(4):535-41. PubMed ID: 27142988 [Abstract] [Full Text] [Related]
88. Update on treatment of immunoglobulin A nephropathy. Zhang YM, Zhang H. Nephrology (Carlton); 2018 Oct 22; 23 Suppl 4():62-67. PubMed ID: 30298661 [Abstract] [Full Text] [Related]
89. Predictors of Progression in IgA Nephropathy in Childhood. Mizerska-Wasiak M, Małdyk J, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Bieniaś B, Zajączkowska M, Miklaszewska M, Pietrzyk J, Demkow U, Roszkowska-Blaim M, Pańczyk-Tomaszewska M. Adv Exp Med Biol; 2017 Oct 22; 955():65-73. PubMed ID: 27718216 [Abstract] [Full Text] [Related]
90. Urinary podocyte can be an indicator for the pathogenetic condition of patients with IgA nephropathy. Shen P, Shen J, Li W, He L. Clin Lab; 2014 Oct 22; 60(10):1709-15. PubMed ID: 25651718 [Abstract] [Full Text] [Related]
91. Neutrophil-to-lymphocyte ratio as an independent inflammatory indicator of poor prognosis in IgA nephropathy. Li Q, Chen P, Shi S, Liu L, Lv J, Zhu L, Zhang H. Int Immunopharmacol; 2020 Oct 22; 87():106811. PubMed ID: 32711375 [Abstract] [Full Text] [Related]
92. A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy. Temurhan S, Akgul SU, Caliskan Y, Artan AS, Kekik C, Yazici H, Demir E, Caliskan B, Turkmen A, Oguz FS, Sever MS. Transplant Proc; 2017 Apr 22; 49(3):541-545. PubMed ID: 28340830 [Abstract] [Full Text] [Related]
93. Urinary mi-106a for the diagnosis of IgA nephropathy: Liquid biopsy for kidney disease. Szeto CC, Ng JK, Fung WW, Chan GC, Luk CC, Lai KB, Wang G, Chow KM, Mac-Moune Lai F. Clin Chim Acta; 2022 May 01; 530():81-86. PubMed ID: 35278407 [Abstract] [Full Text] [Related]
94. A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy. Gao J, Wang Y, Dong Z, Yan Z, Jia X, Tian Y. BMC Med Inform Decis Mak; 2012 Jun 27; 12():58. PubMed ID: 22738421 [Abstract] [Full Text] [Related]
95. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression. Jiang WL, Peng YM, Liu YH, Liu H, Chen GC, Xu XQ, Zhu XJ, Liu FY. Ren Fail; 2012 Jun 27; 34(7):821-6. PubMed ID: 22679920 [Abstract] [Full Text] [Related]
96. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y. Clin Transplant; 2005 Jun 27; 19 Suppl 14():41-8. PubMed ID: 15955168 [Abstract] [Full Text] [Related]
97. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria. Zhong Z, Tang Y, Tan J, Tan L, Pei G, Qin W. Int Urol Nephrol; 2021 Jan 27; 53(1):121-127. PubMed ID: 32944888 [Abstract] [Full Text] [Related]
98. Prediction of corticosteroid responsiveness based on fibroblast-specific protein 1 (FSP1) in patients with IgA nephropathy. Harada K, Akai Y, Yamaguchi Y, Kimura K, Nishitani Y, Nakatani K, Iwano M, Saito Y. Nephrol Dial Transplant; 2008 Oct 27; 23(10):3152-9. PubMed ID: 18463322 [Abstract] [Full Text] [Related]
99. Study of tonsillectomy for IgA nephropathy patients: short- and longer-term observation. Liu Y, Liu H, Tu X, Peng Y, Liu F, Zhang F, Guo C, Liu Y, Yang X, Chen G, Liu Y, Yuan F. Int Urol Nephrol; 2014 Jun 27; 46(6):1153-9. PubMed ID: 24272605 [Abstract] [Full Text] [Related]
100. KIM-1 expression predicts renal outcomes in IgA nephropathy. Kwon SH, Park MY, Jeon JS, Noh H, Choi SJ, Kim JK, Hwang SD, Jin SY, Han DC. Clin Exp Nephrol; 2013 Jun 27; 17(3):359-64. PubMed ID: 23135864 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]